Dr. Eduardo Velez Calderon, MD

Dr. Velez Calderon practices at Mass General Brigham Community Physicians Inc. in Somerville, Massachusetts.

Dr. Velez Calderon's NPI, 1154340271, was assigned on July 19, 2006. Dr. Velez Calderon holds Ohio license 35085547.

Dr. Velez Calderon's primary practice is Mass General Brigham Community Physicians Inc., at 399 Revolution Dr, Somerville, MA 02145 in Middlesex County. The practice phone is (978) 521-3200.

Dr. Velez Calderon's primary practice is Mass General Brigham Community Physicians Inc. in Somerville, Massachusetts. Dr. Velez Calderon is also affiliated with Massachusetts General Hospital. The medical group on file is Mass General Brigham Community Physicians Organization. Dmand AI also links Dr. Velez Calderon to 4 more hospitals, 5 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Velez Calderon practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Velez Calderon's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Velez Calderon is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Velez Calderon is licensed in Ohio.

CMS data shows 1,584 Medicare services from Dr. Velez Calderon across 14 procedure codes in 2024, for 420 Medicare patients. Medicare paid $115,300 for them.

CMS counts 420 Medicare patients who saw Dr. Velez Calderon in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Velez Calderon's median patient age at 72, with 64% women.

In 2024, Dr. Velez Calderon wrote 2,259 Medicare Part D claims for 406 patients. 37% of them were for generic drugs. CMS names the drug for 2,158 of them, across 33 drugs with 11 or more claims each, at $774,820 in total drug cost. In 2023, CMS named 1,499 claims across 29 drugs.

Dr. Velez Calderon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Velez Calderon as offering telehealth.

CMS Open Payments shows 64 general payments to Dr. Velez Calderon from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. GlaxoSmithKline, LLC. paid the most, $570.